Discovery - University of Dundee - Online Publications

Library & Learning Centre

Roland Wolf

  1. Corrigendum to "Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer"

    MacLeod, A. K., Acosta-Jimenez, L., Coates, P. J., McMahon, M., Carey, F. A., Honda, T., Hayes, J. D., Henderson, C. J. & Wolf, C. R. 21 Mar 2017 In : British Journal of Cancer. 1 p.

    Research output: Contribution to journalArticle

  2. Feedback control of AHR signalling regulates intestinal immunity

    Schiering, C., Wincent, E., Metidji, A., Iseppon, A., Li, Y., Potocnik, A. J., Omenetti, S., Henderson, C. J., Wolf, C. R., Nebert, D. W. & Stockinger, B. 9 Feb 2017 In : Nature. 542, p. 242-245

    Research output: Contribution to journalLetter

  3. Aryl hydrocarbon receptor is required for optimal B-cell proliferation

    Villa, M., Gialitakis, M., Tolaini, M., Ahlfors, H., Henderson, C. J., Wolf, C. R., Brink, R. & Stockinger, B. 4 Jan 2017 In : EMBO Journal. 36, p. 116-128 13 p., e201695027

    Research output: Contribution to journalArticle

  4. Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

    MacLeod, A. K., Acosta-Jimenez, L., Coates, P. J., McMahon, M., Carey, F. A., Honda, T., Henderson, C. J. & Wolf, C. R. 6 Dec 2016 In : British Journal of Cancer. 115, 12, p. 1530-1539 10 p.

    Research output: Contribution to journalArticle

  5. Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans

    Takahashi, S., Fukami, T., Masuo, Y., Brocker, C. N., Xie, C., Krausz, K. W., Wolf, C. R., Henderson, C. J. & Gonzalez, F. J. Dec 2016 In : Journal of Lipid Research. 57, p. 2130-2037 8 p.

    Research output: Contribution to journalArticle

  6. Application of Humanised and Other Transgenic Models to Predict Human Responses to Drugs

    Wolf, C. R., Kapelyukh, Y., Scheer, N. & Henderson, C. J. 20 Nov 2016 New Horizons in Predictive drug Metabolism and Pharmocokentics. 49 ed. Royal Society of Chemistry, Vol. 2016-January, p. 152-176 25 p. (RSC Drug Discovery Series; vol. 2016-January, no. 49)

    Research output: Chapter in Book/Report/Conference proceedingChapter

  7. Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π

    Henderson, C. J. , Wolf, C. R. & 19 others McMillan, D. H., van der Velden, J. L. J., Lahue, K. G., Quan, X., Schneider, R. W., Iberg, M. S., Nolin, J. D., Abdalla, S., Casey, D. T., Tew, K. D., Townsend, D. M., Butnor, K. J., Taatjes, D. J., Budd, R. C., Irvin, C. G., van der Vliet, A., Flemer, S., Anathy, V. & Janssen-Heininger, Y. M. W. 2 Jun 2016 In : JCI Insight. 1, 8, 16 p., e85717

    Research output: Contribution to journalArticle

  8. Loss of Tet1-associated 5-hydroxymethylcytosine is concomitant with aberrant promoter hypermethylation in liver cancer

    Thomson, J. P., Ottaviano, R., Unterberger, E. B., Lempiäinen, H., Muller, A., Terranova, R., Illingworth, R. S., Webb, S., Kerr, A. R. W., Lyall, M. J., Drake, A. J., Wolf, C. R., Moggs, J. G., Schwarz, M. & Meehan, R. R. 15 May 2016 In : Cancer Research. 76, 10, p. 3097-3108 12 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...24 Next

Find Researchers in Discovery

Recently Published

Library & Learning Centre

Contact | Accessibility | Policy